Emerging viral respiratory tract infections-environmental risk factors and transmission

The Lancet Infectious Diseases

Volumn 14, Issue 11, 2014, Pages 1113-1122

  Gautret, Philippe ^a,b   Gray, Gregory C ^c   Charrel, Remi N ^d   Odezulu, Nnanyelugo G ^c   Al Tawfiq, Jaffar A ^e   Zumla, Alimuddin ^f   Memish, Ziad A ^g  

^a HÔPITAL NORD   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c UNIVERSITY OF FLORIDA   (United States)

^d Aix Marseille University IRD 190 Inserm 1207   (France)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CORONAVIRUS; DISEASE TRANSMISSION; ENVIRONMENTAL FACTOR; GEOGRAPHIC DISTRIBUTION; HUMAN; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H7N9; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PATHOGENESIS; REVIEW; RISK FACTOR; VIRAL RESPIRATORY TRACT INFECTION; ZOONOSIS; COMMUNICABLE DISEASES, EMERGING; HEALTH; INFECTION CONTROL; ORGANIZATION AND MANAGEMENT; PROCEDURES; RESPIRATORY TRACT INFECTIONS; TRANSMISSION; VIRUS DISEASES;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; GLOBAL HEALTH; HUMANS; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; VIRUS DISEASES;

EID: 84908272781     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70831-X     Document Type: Review

References (126)

1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012, 19:1814-1820.
2. Hijawi B, Abdallat M, Sayaydeh A, et al. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J 2013, 19(suppl 1):S12-S18.
3. Epidemiological update: Middle East respiratory syndrome coronavirus ECDC, (accessed June 12, 2014). http://www.ecdc.europa.eu/en/press/news/_layouts/forms/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568&ID=1016.
4. Khan K, Sears J, Hu VW, et al. Potential for the international spread of Middle East respiratory syndrome in association with mass gatherings in Saudi Arabia. PLoS Curr 2013, 5:1-11.
5. Health regulations for travellers to Saudi Arabia for Umrah and Pilgrimage (Hajj)-1434 H Ministry of Health, Saudi ArabiaSaudi Arabia, (accessed June 12, 2014). http://www.moh.gov.sa/en/HealthAwareness/Hajj/Pages/005.aspx.
6. Gautret P, Benkouiten S, Salaheddine I, et al. Hajj pilgrims knowledge about Middle East respiratory syndrome coronavirus, August to September 2013. Euro Surveill 2013, 18:20604.
7. Gautret P, Benkouiten S, Salaheddine I, Parola P, Brouqui P Preventive measures against MERS-CoV for Hajj pilgrims. Lancet Infect Dis 2013, 13:829-831.
8. WHO statement on the third meeting of the IHR Emergency committee concerning Middle East respiratory syndrome coronavirus (MERS-CoV). Wkly Epidemiol Rec 2013, 88:435-436. WHO.
9. Gautret P, Charrel R, Belhouchat K, et al. Lack of nasal carriage of novel coronavirus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms. Clin Microbiol Infect 2013, 19:E315-E317.
10. Gautret P, Charrel R, Benkouiten S, et al. Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis 2014, 20:726-728.
11. Benkouiten S, Charrel R, Belhouchat K, et al. Circulation of respiratory viruses among pilgrims during the 2012 Hajj pilgrimage. Clin Infect Dis 2013, 57:992-1000.
12. Memish ZA, Assiri A, Almasri M, et al. Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj. J Infect Dis 2014, published online April 15. 10.1093/infdis/jiu150.
13. State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in Humans. PLoS Curr 2013, 5:1-13. WHO MERS-CoV Research Group.
14. Assiri A, McGeer A, Perl TM, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 2013, 369:407-416.
15. Cotten M, Watson SJ, Kellam P, et al. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet 2013, 382:1993-2002.
16. Memish ZA, Zumla AI, Al-Hakeem RF, Al-Rabeeah AA, Stephens GM Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med 2013, 368:2487-2494.
17. Omrani AS, Matin MA, Haddad Q, Al-Nakhli D, Memish ZA, Albarrak AM A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case. Int J Infect Dis 2013, 17:e668-e672.
18. Breban R, Riou J, Fontanet A Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 2013, 382:694-699.
19. Cauchemez S, Fraser C, Van Kerkhove MD, et al. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis 2014, 14:50-56.
20. Drexler JF, Corman VM, Drosten C Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. Antiviral Res 2014, 101:45-56.
21. Ithete NL, Stoffberg S, Corman VM, et al. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis 2013, 19:1697-1699.
22. Annan A, Baldwin HJ, Corman VM, et al. Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg Infect Dis 2013, 19:456-459.
23. Cotten M, Lam TT, Watson SJ, et al. Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus. Emerg Infect Dis 2013, 19:736-742.
24. Wacharapluesadee S, Sintunawa C, Kaewpom T, et al. Group C betacoronavirus in bat guano fertilizer, Thailand. Emerg Infect Dis 2013, 19:1349-1351.
25. van Boheemen S, de Graaf M, Lauber C, et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 2012, 3:1-9.
26. Anthony SJ, Ojeda-Flores R, Rico-Chavez O, et al. Coronaviruses in bats from Mexico. J Gen Virol 2013, 94:1028-1038.
27. Lau SK, Woo PC, Li KS, et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci USA 2005, 102:14040-14045.
28. Corman VM, Kallies R, Philipps H, et al. Characterization of a novel betacoronavirus related to Middle East respiratory syndrome coronavirus in European hedgehogs. J Virol 2014, 88:717-724.
29. Drosten C, Seilmaier M, Corman VM, et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 2013, 13:745-751.
30. Reusken CB, Haagmans BL, Muller MA, et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis 2013, 13:859-866.
31. Haagmans BL, Al Dhahiry SH, Reusken CB, et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis 2014, 14:140-145.
32. Perera RA, Wang P, Gomaa MR, et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill 2013, 18:1-7.
33. Alagaili AN, Briese T, Mishra N, et al. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio 2014, 5:e01146. e01114.
34. Meyer B, Muller MA, Corman VM, et al. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis 2014, 20:552-559.
35. Woo PC, Lau SK, Wernery U, et al. Novel betacoronavirus in dromedaries of the Middle East, 2013. Emerg Infect Dis 2014, 20:560-572.
36. Hemida MG, Perera RA, Wang P, et al. Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. Euro Surveill 2013, 18:20659.
37. Reusken CB, Ababneh M, Raj VS, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013. Euro Surveill 2013, 18:20662.
38. Chu DKW, Poon LLM Gomaa MM, et al. MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis 2014, 20:1049-1053.
39. Nowotny N, Kolodziejek J Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013. Euro Surveill 2014, 19:20781.
40. Memish ZA, Cotten M, Meyer B, et al. Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis 2014, 20:1012-1015.
41. Azhar EI, El-Kafrawy SA, Farraj SA, et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 2014, published online June 4. 10.1056/NEJMoa1401505.
42. Memish ZA, Mishra N, Olival KJ, et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis 2013, 19:1819-1823.
43. Aburizaiza AS, Mattes FM, Azhar EI, et al. Investigation of antiMiddle-East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012. J Infect Dis 2014, 209:243-246.
44. Gierer S, Hofmann-Winkler H, Albuali WH, et al. Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia. Emerg Infect Dis 2013, 19:2034-2036.
45. Reusken CB, Farag EA, Jonges M, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014. Euro Surveill 2014, 19:1-5.
46. van Doremalen N, Bushmaker T, Munster VJ Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Emerg Infec Dis 2014, 20:1263-1264.
47. Al-Tawfiq JA, Assiri A, Memish ZA Middle East respiratory syndrome novel corona MERS-CoV infection. Epidemiology and outcome update. Saudi Med J 2013, 34:991-994.
48. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013, 13:752-761.
49. Goh GK, Dunker AK, Uversky V Prediction of intrinsic disorder in MERS-CoV/HCoV-EMC supports a high oral-fecal transmission. PLoS Curr 2013, 5:1-22.
50. van der Veen J, Kok G Isolation and typing of adenoviruses recovered from military recruits with acute respiratory disease in the Netherlands. Am J Hyg 1957, 65:119-129.
51. Bruj J, Farnik J, Sedmidubsky V Epidemic of acute respiratory disease due to adenovirus type 14. Cesk Epidemiol Mikrobiol Imunol 1966, 15:165-171.
52. Mevzos LM, Il'ina TS, Makhmudov OS, Zolotarskaia EE, Dreizin RS An outbreak of acute respiratory infections among adults caused by adenovirus serotype 14. Vopr Virusol 1966, 11:426-431.
53. Kajon AE, Lu X, Erdman DD, et al. Molecular epidemiology and brief history of emerging adenovirus 14-associated respiratory disease in the United States. J Infect Dis 2010, 202:93-103.
54. Kendall EJC, Riddle RW, Tuck HA, Rodan KS, Andrews BE, McDonald JC Pharyngo-conjunctival fever: school outbreaks in England during the summer of 1955 associated with adenovirus types 3, 7, and 14. BMJ 1957, 2:131-136.
55. Chen HL, Chiou SS, Hsiao HP, et al. Respiratory adenoviral infections in children: a study of hospitalized cases in southern Taiwan in 2001-2002. J Trop Pediatr 2004, 50:279-284.
56. Metzgar D, Osuna M, Kajon AE, Hawksworth AW, Irvine M, Russell KL Abrupt emergence of diverse species B adenoviruses at US military recruit training centers. J Infect Dis 2007, 196:1465-1473.
57. Tate JE, Bunning ML, Lott L, et al. Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007. J Infect Dis 2009, 199:1419-1426.
58. Acute respiratory disease associated with adenovirus serotype 14-four states, 2006-2007. MMWR Morb Mortal Wkly Rep 2007, 56:1181-1184.
59. Gardner T MJ Outbreak of adenovirus 14 respiratory illness-Prince of Wales Island, 2008. MMWR Morb Mortal Wkly Rep 2010, 59:6-10.
60. Selvaraju SB, Kovac M, Dickson LM, Kajon AE, Selvarangan R Molecular epidemiology and clinical presentation of human adenovirus infections in Kansas City children. J Clin Virol 2011, 51:126-131.
61. O'Flanagan D, O'Donnell J, Domegan L, et al. First reported cases of human adenovirus serotype 14p1 infection, Ireland, October 2009 to July 2010. Euro Surveill 2011, 16:1-5.
62. Zhang Q, Seto D, Zhao S, Zhu L, Zhao W, Wan C Genome sequence of the first human adenovirus type 14 isolated in China. J Virol 2012, 86:7019-7020.
63. Tang L, An J, Xie Z, et al. Genome and bioinformatic analysis of a HAdV-B14p1 virus isolated from a baby with pneumonia in Beijing, China. PLoS One 2013, 8:1-8.
64. Huang G, Yu D, Zhu Z, et al. Outbreak of febrile respiratory illness associated with human adenovirus type 14p1 in Gansu Province, China. Influenza Other Respir Viruses 2013, 7:1048-1054.
65. Girouard G, Garceau R, Thibault L, Oussedik Y, Bastien N, Li Y Adenovirus serotype 14 infection, New Brunswick, Canada, 2011. Emerg Infect Dis 2013, 19:119-122.
66. Russell KL, Broderick MP, Franklin SE, et al. Transmission dynamics and prospective environmental sampling of adenovirus in a military recruit setting. J Infect Dis 2006, 194:877-885.
67. Chen EC, Yagi S, Kelly KR, et al. Cross-species transmission of a novel adenovirus associated with a fulminant pneumonia outbreak in a new world monkey colony. PLoS Pathog 2011, 7:1-48.
68. Chiu CY, Yagi S, Lu X, et al. A novel adenovirus species associated with an acute respiratory outbreak in a baboon colony and evidence of coincident human infection. MBio 2013, 4:1-12.
69. Harrach B, Benkö M, Both GW, et al. Family Adenoviridae in virus taxonomy: ninth report of the International Committee on Taxonomy of Viruses 2013, 125-141. Academic Press, San Diego.
70. Roy S, Vandenberghe LH, Kryazhimskiy S, et al. Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates. PLoS Pathog 2009, 5:1-9.
71. Abzug MJ, Levin MJ Neonatal adenovirus infection: four patients and review of the literature. Pediatrics 1991, 87:890-896.
72. Porter JD, Teter M, Traister V, Pizzutti W, Parkin WE, Farrell J Outbreak of adenoviral infections in a long-term paediatric facility, New Jersey, 1986-87. J Hosp Infect 1991, 18:201-210.
73. Chakrabarti S, Mautner V, Osman H, et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002, 100:1619-1627.
74. Hierholzer JC Adenoviruses in the immunocompromised host. Clin Microbiol Rev 1992, 5:262-274.
75. Shi B, Xia S, Yang GJ, Zhou XN, Liu J Inferring the potential risks of H7N9 infection by spatiotemporally characterizing bird migration and poultry distribution in eastern China. Infect Dis Poverty 2013, 2:8.
76. Li J, Yu X, Pu X, et al. Environmental connections of novel avian-origin H7N9 influenza virus infection and virus adaptation to the human. Sci China Life Sci 2013, 56:485-492.
77. Avian Flu (H7N9) CDC, (accessed June 12, 2014). http://wwwnc.cdc.gov/travel/notices/watch/avian-flu-h7n9-china.
78. Human infection with avian influenza A(H7N9) virus-update WHO, (accessed June 12, 2014). http://www.who.int/csr/don/2014_03_20_h7n9/en/.
79. Shi J, Xie J, He Z, Hu Y, He Y, Huang Q, et al. A detailed epidemiological and clinical description of 6 human cases of avian-origin influenza A (H7N9) virus infection in Shanghai. PLoS One 2013, 8:1-8.
80. Gao R, Cao B, Hu Y, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013, 368:1888-1897.
81. Qi X, Qian YH, Bao CJ, et al. Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ 2013, 347:1-8.
82. Tang RB, Chen HL An overview of the recent outbreaks of the avian-origin influenza A (H7N9) virus in the human. J Chin Med Assoc 2013, 76:245-248.
83. Noah DL, Noah JW Adapting global influenza management strategies to address emerging viruses. Am J Physiol Lung Cell Mol Physiol 2013, 305:L108-L117.
84. To KK, Chan JF, Chen H, Li L, Yuen KY The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect Dis 2013, 13:809-821.
85. Wang L, Zhang W, Magalhaes RJ, et al. Geographic codistribution of influenza virus subtypes H7N9 and H5N1 in humans, China. Emerg Infect Dis 2013, 19:1898-1900.
86. Chowell G, Simonsen L, Towers S, Miller MA, Viboud C Transmission potential of influenza A/H7N9, February to May 2013, China. BMC Med 2013, 11:214.
87. Nishiura H, Mizumoto K, Ejima K How to interpret the transmissibility of novel influenza A(H7N9): an analysis of initial epidemiological data of human cases from China. Theor Biol Med Model 2013, 10:30.
88. Ai J, Huang Y, Xu K, Ren D, Qi X, Ji H, et al. Case-control study of risk factors for human infection with influenza A(H7N9) virus in Jiangsu Province, China, 2013. Euro Surveill 2013, 18:20510.
89. Li Q, Zhou L, Zhou M, et al. Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med 2014, 370:520-532.
90. Zhang Z, Xia Y, Lu Y, et al. Prediction of H7N9 epidemic in China. Chin Med J (Engl) 2014, 127:254-260.
91. Prosser DJ, Hungerford LL, Erwin RM, Ottinger MA, Takekawa JY, Ellis EC Mapping avian influenza transmission risk at the interface of domestic poultry and wild birds. Front Public Health 2013, 1:28.
92. Pepin KM, Lloyd-Smith JO, et al. Minimizing the threat of pandemic emergence from avian influenza in poultry systems. BMC Infect Dis 2013, 13:592.
93. Garcia-Sastre A, Schmolke M Avian influenza A H10N8-a virus on the verge?. Lancet 2014, 383:676-677.
94. Parry J H10N8 avian flu virus claims its first known human casualty. BMJ 2014, 348:1.
95. To KK, Tsang AK, Chan JF, Cheng VC, Chen H, Yuen KY Emergence in China of human disease due to avian influenza A(H10N8)-cause for concern?. J Infect 2014, 68:205-215.
96. Zhang H, Xu B, Chen Q, Chen J, Chen Z Characterization of an H10N8 influenza virus isolated from Dongting lake wetland. Virol J 2011, 8:42.
97. Pearce MB, Jayaraman A, Pappas C, et al. Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets. Proc Natl Acad Sci USA 2012, 109:3944-3949.
98. Jhung MA, Epperson S, Biggerstaff M, et al. Outbreak of variant influenza A(H3N2) virus in the United States. Clin Infect Dis 2013, 57:1703-1712.
99. Epperson S, Jhung M, Richards S, et al. Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012. Clin Infect Dis 2013, 57(suppl 1):S4-11.
100. Eibach D, Casalegno JS, Bouscambert M, et al. Routes of transmission during a nosocomial influenza A(H3N2) outbreak among geriatric patients and healthcare workers. J Hosp Infect 2014, 86:188-193.
101. Antibodies crossreactive to influenza A (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccine on cross-reactive antibodies- United States. MMWR Morb Mortal Wkly Rep 2012, 61:237-241.
102. Houser KV, Katz JM, Tumpey TM Seasonal trivalent inactivated influenza vaccine does not protect against newly emerging variants of influenza A (H3N2v) virus in ferrets. J Virol 2013, 87:1261-1263.
103. Influenza A (H3N2) variant virus-related hospitalizations: Ohio, 2012. MMWR Morb Mortal Wkly Rep 2012, 61:764-767.
104. Biggerstaff M, Reed C, Epperson S, et al. Estimates of the number of human infections with influenza A(H3N2) variant virus, United States, August 2011-April 2012. Clin Infect Dis 2013, 57(suppl 1):S12-S15.
105. Gray GC, Cao WC Editorial commentary: variant Influenza A(H3N2) virus: looking through a glass, darkly. Clin Infect Dis 2013, 57:1713-1714.
106. Houser KV, Pearce MB, Katz JM, Tumpey TM Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets. J Virol 2013, 87:13480-13489.
107. Feng Z, Gomez J, Bowman AS, et al. Antigenic characterization of H3N2 influenza A viruses from Ohio agricultural fairs. J Virol 2013, 87:7655-7667.
108. Weekly epidemiological record Update on human cases of influenza at the human-animal interface, 2012 WHO, (accessed June 12, 2014). http://www.who.int/wer/2013/wer8813.pdf?ua=1.
109. Bragstad K, Emborg H, Fischer TK, et al. Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13-a rapid epidemiological and virological assessment. Euro Surveill 2013, 18:11-17.
110. Galiano M, Johnson BF, Myers R, Ellis J, Daniels R, Zambon M Fatal cases of influenza A(H3N2) in children: insights from whole genome sequence analysis. PLoS One 2012, 7:e33166.
111. DE Donno A, Idolo A, Quattrocchi M, et al. Surveillance of human influenza A(H3N2) virus from 1999 to 2009 in southern Italy. Epidemiol Infect 2014, 142:933-939.
112. Chan MC, Lee N, Ngai KL, et al. A "preseasonal" hospital outbreak of influenza pneumonia caused by the drift variant A/Victoria/361/2011-like H3N2 viruses, Hong Kong, 2011. J Clin Virol 2013, 56:219-225.
113. Kishida N, Imai M, Xu H, et al. Seroprevalence of a novel influenza A (H3N2) variant virus in the Japanese population. Jpn J Infect Dis 2013, 66:549-551.
114. Shortridge KF, Webster RG Geographical distribution of swine (Hsw1N1) and Hong Kong (H3N2) influenza virus variants in pigs in Southeast Asia. Intervirology 1979, 11:9-15.
115. Prevention, C.C.f.D.C.a. interim guidance for enhanced influenza surveillance: additional specimen collection for detection of influenza A (H3N2) variant virus infections (accessed June 12, 2014). http://www.cdc.gov/flu/swineflu/h3n2v-surveillance.htm.
116. Skowronski DM, Janjua NZ, De Serres G, et al. Crossreactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). J Infect Dis 2012, 206:1852-1861.
117. USDA United States Department of Agriculture, A.R.S. Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012 (accessed June 12, 2014). http://www.ncaur.usda.gov/research/publications/Publications.htm?seq_no_115=297894.
118. Wong KK, Greenbaum A, Moll ME, et al. Outbreak of influenza A (H3N2) variant virus infection among attendees of an agricultural fair, Pennsylvania, USA, 2011. Emerg Infect Dis 2012, 18:1937-1944.
119. Finelli L, Swerdlow DL The emergence of influenza A (H3N2)v virus: what we learned from the first wave. Clin Infect Dis 2013, 57(suppl 1):S1-S3.
120. Tharakaraman K, Raman R, Stebbins NW, Viswanathan K, Sasisekharan V, Sasisekharan R Antigenically intact hemagglutinin in circulating avian and swine influenza viruses and potential for H3N2 pandemic. Sci Rep 2013, 3:1822.
121. Notes from the field: Outbreak of influenza A (H3N2) virus among persons and swine at a county fair-Indiana, July 2012. MMWR Morb Mortal Wkly Rep 2012, 61:561.
122. Update: Influenza A (H3N2)v transmission and guidelines-five states, 2011. MMWR Morb Mortal Wkly Rep 2012, 60:1741-1744.
123. Gray GC Adenovirus transmission-worthy of our attention. J Infect Dis 2006, 194:871-873.
124. Gray GC, Chorazy ML Human adenovirus 14a: a new epidemic threat. J Infect Dis 2009, 199:1413-1415.
125. Metzgar D, Skochko G, Gibbins C, Hudson N, Lott L, Jones MS Evaluation and validation of a real time PCR assay for detection and quantitation of human adenovirus 14 from clinical samples. PLoS One 2009, 4:1-6.
126. Lam TT, Wang J, Shen Y, et al. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature 2013, 502:241-244.